Literature DB >> 31346595

Hepatitis C Virus Reinfection Rate Among Persons Who Use Drugs and Are Maintained on Medication Treatment for Opioid Use Disorder.

Sandra A Springer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31346595      PMCID： PMC7286379          DOI： 10.1093/cid/ciz695

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  26 in total

1.  Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

Authors:  Jason Grebely; Olav Dalgard; Brian Conway; Evan B Cunningham; Philip Bruggmann; Behzad Hajarizadeh; Janaki Amin; Julie Bruneau; Margaret Hellard; Alain H Litwin; Philippa Marks; Sophie Quiene; Sharmila Siriragavan; Tanya L Applegate; Tracy Swan; Jude Byrne; Melanie Lacalamita; Adrian Dunlop; Gail V Matthews; Jeff Powis; David Shaw; Maria Christine Thurnheer; Martin Weltman; Ian Kronborg; Curtis Cooper; Jordan J Feld; Chris Fraser; John F Dillon; Phillip Read; Ed Gane; Gregory J Dore
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-01-06

2.  Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.

Authors:  Matthew J Akiyama; Brianna L Norton; Julia H Arnsten; Linda Agyemang; Moonseong Heo; Alain H Litwin
Journal:  Ann Intern Med       Date:  2019-04-09       Impact factor: 25.391

3.  Nonopioid Overdose Death Rates Rose Almost As Fast As Those Involving Opioids, 1999-2016.

Authors:  Christopher J Ruhm
Journal:  Health Aff (Millwood)       Date:  2019-07       Impact factor: 6.301

4.  Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Authors:  Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Breanne E Biondi; Maureen Desabrais; Thomas Lincoln; Daniel J Skiest; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

5.  Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop.

Authors:  Sandra A Springer; P Todd Korthuis; Carlos Del Rio
Journal:  Ann Intern Med       Date:  2018-07-13       Impact factor: 25.391

6.  Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.

Authors:  Matthew J Akiyama; Daniel Lipsey; Moonseong Heo; Linda Agyemang; Brianna L Norton; Jennifer Hidalgo; Kiara Lora; Alain H Litwin
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

7.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

8.  Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.

Authors:  Matthew J Akiyama; Linda Agyemang; Julia H Arnsten; Moonseong Heo; Brianna L Norton; Bruce R Schackman; Benjamin P Linas; Alain H Litwin
Journal:  BMC Infect Dis       Date:  2018-02-09       Impact factor: 3.667

9.  Notes from the Field: HIV Diagnoses Among Persons Who Inject Drugs - Northeastern Massachusetts, 2015-2018.

Authors:  Kevin Cranston; Charles Alpren; Betsey John; Erica Dawson; Kathleen Roosevelt; Amanda Burrage; Janice Bryant; William M Switzer; Courtney Breen; Philip J Peters; Tracy Stiles; Ashley Murray; H Dawn Fukuda; William Adih; Linda Goldman; Nivedha Panneer; Barry Callis; Ellsworth M Campbell; Liisa Randall; Anne Marie France; R Monina Klevens; Sheryl Lyss; Shauna Onofrey; Christine Agnew-Brune; Michael Goulart; Hongwei Jia; Matthew Tumpney; Paul McClung; Sharoda Dasgupta; Danae Bixler; Kischa Hampton; Jenifer Leaf Jaeger; Kate Buchacz; Alfred DeMaria
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-15       Impact factor: 17.586

10.  Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.

Authors:  Natasha K Martin; Peter Vickerman; Jason Grebely; Margaret Hellard; Sharon J Hutchinson; Viviane D Lima; Graham R Foster; John F Dillon; David J Goldberg; Gregory J Dore; Matthew Hickman
Journal:  Hepatology       Date:  2013-08-26       Impact factor: 17.425
View more
  2 in total

1.  Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes!

Authors:  Sandra A Springer; Carlos Del Rio
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 2.  A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes.

Authors:  Katelyn F McNamara; Breanne E Biondi; Raúl U Hernández-Ramírez; Noor Taweh; Alyssa A Grimshaw; Sandra A Springer
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.